EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ketogenic Diet and Black Seed Oil (Nigella sativa) Combination Overcomes Doxorubicin Resistance in Breast Cancer: An In Vitro and In Vivo Study

Rawan W Hadi, Majida Al Wraikat, Moudi M Alasmari, Doaa Anbarserry iD, Wamidh H Talib iD, Bence Raposa iD

Nutrients · 30.10.2026 · 18 (21) · 3610

DOI: 10.3390/nu18213610 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 30.10.2026. Verfasst von Rawan W Hadi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition and Dietetics, Applied Science Private University, Amman 11931, Jordan. Hauptthemen laut MEDLINE: Doxorubicin, Plant Oils, Drug Resistance, Neoplasm, Diet, Ketogenic. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Applied Science Private University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study evaluated the effects of black seed oil (BSO), a simulated ketogenic metabolic condition consisting of a low-glucose medium supplemented with 5 mM β-hydroxybutyrate (BHB), and their combination in EMT6/P and EMT6/DOX cells. The in vivo effects of a ketogenic diet, BSO, and their combination were also investigated in tumor-bearing mice.

Methods

Cytotoxicity of black seed oil (BSO), a simulated ketogenic metabolic condition consisting of low-glucose medium supplemented with 5 mM β-hydroxybutyrate (BHB), their combination, and doxorubicin (DOX) was evaluated in EMT6/P and EMT6/DOX cells using the MTT assay. Combination index (CI) analysis was used to determine the interaction between BSO and the simulated ketogenic metabolic condition. Caspase-3 activity, vascular endothelial growth factor VEGF expression, and P-glycoprotein (P-gp) expression were evaluated in EMT6/DOX cells. In vivo, mice bearing EMT6/P and EMT6/DOX tumors received a ketogenic diet, BSO, their combination, DOX, and control treatment, and tumor growth, tumor weight, tumor-free rate, and serum biochemical parameters were assessed.

Results

BSO half-maximal inhibitory concentration IC50 was 14.5-fold higher in EMT6/DOX than in EMT6/P, and DOX IC50 was 39.5-fold higher. The simulated ketogenic metabolic condition consisting of a low-glucose medium supplemented with 5 mM BHB + BSO combination gave a CI of 0.1244 in EMT6/P and 0.0239 in EMT6/DOX, indicating synergism in both lines. The combination produced the highest caspase-3 activity (1.54-fold vs. control), the lowest VEGF level (268.34 pg/mL vs. 953.34 pg/mL in control), and the lowest P-gp level (1.6 ng/mL vs. 3.7 ng/mL in control) among the treatments tested. In vivo, the combination reduced tumor volume by 87.15% in EMT6/P and 58.12% in EMT6/DOX, and gave a tumor-free rate of 66.6% in EMT6/P and 50% in EMT6/DOX. No consistent treatment-related change was observed in liver enzymes, renal markers, or lipid profile compared with healthy controls.

Conclusions

The combination of a simulated ketogenic metabolic condition and BSO showed synergistic cytotoxic activity in vitro, while the ketogenic diet and BSO combination produced enhanced antitumor activity in vivo. These effects were associated with increased caspase-3 activity and reduced VEGF and P-gp expression in EMT6/DOX cells, without evidence of hepatic, renal, or metabolic toxicity. These findings support further investigation of this combination in doxorubicin-resistant breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinPlant OilsDrug Resistance, NeoplasmDiet, KetogenicBreast NeoplasmsAnimalsFemaleCell Line, TumorMiceVascular Endothelial Growth Factor ACaspase 3ATP Binding Cassette Transporter, Subfamily B, Member 1Antibiotics, AntineoplasticApoptosis3-Hydroxybutyric AcidSeedsMice, Inbred BALB C

Stichwörter der Autor:innen

Nigella sativaP-glycoproteinVEGFapoptosisblack seed oilbreast cancerdoxorubicin resistanceketogenic dietsynergismβ-hydroxybutyrate

Substanzen

DoxorubicinPlant OilsVascular Endothelial Growth Factor ACaspase 3ATP Binding Cassette Transporter, Subfamily B, Member 1Antibiotics, Antineoplastic3-Hydroxybutyric Acid

Autor:innen und Institutionen

  • Department of Clinical Nutrition and Dietetics, Applied Science Private University, Amman 11931, Jordan.
  • College of Medicine, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Jeddah 21589, Saudi Arabia.
  • King Abdullah International Medical Research Centre (KAIMRC), Jeddah 21589, Saudi Arabia.
  • Ministry of National Guard Health Affairs (MNGHA), Jeddah 21589, Saudi Arabia.
  • Department of Clinical Pharmacology, Faculty of Medicine, King Abdulaziz University, Rabigh 21911, Saudi Arabia.
  • Faculty of Allied Medical Sciences, Applied Science Private University, Amman 11931, Jordan.

ORCID-Profile: Doaa Anbarserry, Wamidh H Talib, Bence Raposa

Förderung

  • Applied Science Private University

Zitieren

APA

Hadi, R. W., Wraikat, M. A., Alasmari, M. M., Anbarserry, D., Talib, W. H., & Raposa, B. (2026). Ketogenic Diet and Black Seed Oil (Nigella sativa) Combination Overcomes Doxorubicin Resistance in Breast Cancer: An In Vitro and In Vivo Study. Nutrients, 18(21), 3610. https://doi.org/10.3390/nu18213610

Vancouver

Hadi RW, Wraikat MA, Alasmari MM, Anbarserry D, Talib WH, Raposa B. Ketogenic Diet and Black Seed Oil (Nigella sativa) Combination Overcomes Doxorubicin Resistance in Breast Cancer: An In Vitro and In Vivo Study. Nutrients. 2026;18(21):3610. doi:10.3390/nu18213610

BibTeX
@article{Hadi2026,
  author = {Hadi, Rawan W and Wraikat, Majida Al and Alasmari, Moudi M and Anbarserry, Doaa and Talib, Wamidh H and Raposa, Bence},
  title = {Ketogenic Diet and Black Seed Oil (Nigella sativa) Combination Overcomes Doxorubicin Resistance in Breast Cancer: An In Vitro and In Vivo Study},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {21},
  pages = {3610},
  doi = {10.3390/nu18213610}
}
Kostenlos starten →